Endpoints News
Merck partners with Flagship startup Quotient to search for genetic clues to IBD
Quotient Therapeutics, a startup studying how tiny genetic typos cause some cells to get sick but allow others to remain healthy, has struck a partnership with Merck.
The partnership will identify new drug targets for …